Clinical implications of receptor conversions in breast cancer patients who have undergone neoadjuvant chemotherapy-Reference-Cited by-同舟云学术

Clinical implications of receptor conversions in breast cancer patients who have undergone neoadjuvant chemotherapy

Published:2023-05-26 Issue:2 Volume:200 Page:247-256
ISSN:0167-6806
Container-title:Breast Cancer Research and Treatment
language:en
Short-container-title:Breast Cancer Res Treat

Author:

Vemuru Sudheer^ORCID,Huang Jin,Colborn Kathryn,Yoon YooJin,Huynh Victoria,Leonard Laura,Ahrendt Gretchen,Christian Nicole,Afghahi Anosheh,McLemore Lauren,Sams Sharon,Tevis Sarah

Funder

Comprehensive Cancer Center, City of Hope

Cancer Center, University of Colorado

Doris Duke Charitable Foundation

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

https://link.springer.com/content/pdf/10.1007/s10549-023-06978-0.pdf

Reference34 articles.

1. Mauri D, Pavlidis N, Ioannidis JP (2005) Neoadjuvant versus adjuvant systemic treatment in breast cancer: a meta-analysis. J Natl Cancer Inst 97(3):188–194. https://doi.org/10.1093/jnci/dji021

2. Caudle AS, Yang WT, Krishnamurthy S et al (2016) Improved axillary evaluation following neoadjuvant therapy for patients with node-positive breast cancer using selective evaluation of clipped nodes: implementation of targeted axillary dissection. J Clin Oncol 34(10):1072–1078. https://doi.org/10.1200/JCO.2015.64.0094

3. Duffy MJ, Harbeck N, Nap M et al (2017) Clinical use of biomarkers in breast cancer: updated guidelines from the European group on tumor markers (EGTM). Eur J Cancer 75:284–298. https://doi.org/10.1016/j.ejca.2017.01.017

4. Trialist C, Group C (2005) Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. The Lancet 365(9472):1687–1717. https://doi.org/10.1016/S0140-6736(05)66544-0

5. Jin X, Jiang YZ, Chen S, Yu KD, Shao ZM, Di GH (2015) Prognostic value of receptor conversion after neoadjuvant chemotherapy in breast cancer patients: a prospective observational study. Oncotarget 6(11):9600–9611. https://doi.org/10.18632/oncotarget.3292

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Does immunohistochemical marker conversion affect the prognosis in breast cancer patients receiving neoadjuvant chemotherapy?;Scientific Reports;2024-06-25

2. Changing the phenotype of breast cancer in the process treatment: literature review;Surgery and Oncology;2024-01-04